23
Participants
Start Date
September 6, 2017
Primary Completion Date
March 4, 2022
Study Completion Date
March 4, 2022
Harvoni
One capsule of Harvoni/ ledipasvir, 90 mg + sofosbuvir, 400 mg administered daily for 8, 12, or 24 weeks
Wake Forest University Health Sciences, Winston-Salem
University of Texas Medical Branch, Galveston
University of California, San Francisco, San Francisco
Collaborators (1)
Gilead Sciences
INDUSTRY
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
National Institutes of Health (NIH)
NIH
Wake Forest University Health Sciences
OTHER